A pharmacological analysis of the rat mast cell 5‐HT gastric lesion test and the effects of ketanserin
- 1 January 1985
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 5 (4), 303-312
- https://doi.org/10.1002/ddr.430050403
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Experience With Ketanserin, A Serotonin (S2) Antagonist, in Longterm Treatment of Essential HypertensionClinical and Experimental Hypertension. Part A: Theory and Practice, 1984
- The Effect of Ketanserin on Blood Pressure and Biochemical Parameters in Treated Patients with Essential HypertensionClinical and Experimental Hypertension. Part A: Theory and Practice, 1984
- 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.Hypertension, 1984
- THE EFFECT OF KETANSERIN IN ESSENTIAL HYPERTENSIONClinical and Experimental Pharmacology and Physiology, 1983
- Ketanserin in HypertensionActa Medica Scandinavica, 1983
- Ketanserin in essential hypertension: Effects during rest and exerciseEuropean Journal of Clinical Pharmacology, 1983
- Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonistInflammation Research, 1982
- Direct measurement of the pH in the stomach of the conscious rat, using a special electrodeCellular and Molecular Life Sciences, 1979
- Minireview A systematic study of the pharmacological activities of dopamine antagonistsLife Sciences, 1979
- Induction of acute gastric lesions by histamine liberators in ratsJournal of Allergy, 1959